Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Natco Pharma is the first company to launch semaglutidethe active pharmaceutical ingredient in Ozempic, Wegovy and Mounjaroin vial form
[6, 7, 8] But the effect only lasts for a couple of minutes, as opposed to GLP-1 medicationswhich last for a week
In the major STEP-1 clinical trial published in the New England Journal of Medicine, patients lost about 15% of body weight over 68 weeks on semaglutide plus lifestyle intervention
Funding This work is funded by KBRI (25-BR-02-01, 25-BR-05-01), the Ministry of Trade, Industry and Energy (RS-2024-00507932), and by the Ministry of Science and ICT (2022R1A5A202954611 and RS-2025-16065563)
Safety Profile No significant cortisol increase No prolactin elevation Mild side effects possible: Water retention Hunger increase Injection site irritation Medical supervision is always recommended
US$ 23.11
US$ 24.93
US$ 22.07
US$ 26.84
